Clinical trials
Obesity clinical trials
Excess body weight that increases the risk of many other health conditions. We’re tracking 1,434 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07037459RecruitingPhase 3
A study of a new drug for heart failure with obesity
This trial tests a medication called maridebart cafraglutide for people with heart failure (where the heart doesn't pump as well as it should) and obesity. The goal is to see if it can help improve symptoms and outcomes.
Birmingham, AlabamaAges 18–99 - NCT07038252Recruiting
Oral supplement effect on blood vessel health in obesity and hypertension
This trial tests whether an oral supplement made from special fats (called Specialized Pro-resolving Mediators) can help reduce blood vessel damage caused by inflammation in people with obesity and high blood pressure. If you have well-controlled high blood pressure and are obese, you may be able to join.
ParisAges 18–85 - NCT06742710RecruitingPhase 4
Liraglutide for obese infertility in PCOS
This trial tests if liraglutide, a weight-loss medication, can help obese women with PCOS who have a frozen embryo achieve pregnancy. It aims to improve fertility outcomes by aiding weight loss before embryo transfer.
Beijing, Beijing MunicipalityAges 20–40 - NCT07032545Recruiting
Broccoli microgreens study for obese breast cancer survivors
This trial tests if eating broccoli microgreens can improve metabolism in obese breast cancer survivors. Participants will avoid other cruciferous vegetables during the study to see how the microgreens affect their health.
Baltimore, MarylandAges Any age - NCT07033221Recruiting
Balance and inner ear function in obesity
This study looks at how obesity affects your sense of balance (vestibular function). It compares people with obesity who are candidates for weight-loss surgery to people without obesity, to see if weight affects balance.
Istanbul, KüçükçekmeceAges 18–60 - NCT07027033Recruiting
Oleic acid's effect on cholesterol metabolism in women with obesity
This study tests whether a special type of fatty acid (oleic acid) can change how the body handles cholesterol in women with obesity who are having weight-loss surgery. It will help researchers understand if this nutrient can improve cholesterol metabolism and reduce insulin resistance.
Nantes, FranceAges 18–60 - NCT07031297Recruiting
Exosome release after a meal in obesity
This study looks at how the body releases tiny particles called exosomes from the upper arm after a meal, specifically in women with obesity. It helps researchers understand how fat tissue responds to eating.
Rochester, MinnesotaAges 18–55 - NCT07018544Enrolling by invitation
Wegovy safety and effectiveness study in Korea
This study watches how Wegovy (semaglutide) works and its side effects when given by doctors to patients with obesity or overweight in South Korea. It is not testing a new drug, but collecting information from routine care.
Goyang-si, Gyeonggi-doAges 19 years+ - NCT07020741Recruiting
Stable isotope study in adults with obesity
This study uses a special test (stable isotopes) to learn about how adults with obesity process food and energy. It may help researchers understand weight and metabolism better.
Urbana, IllinoisAges 19–59 - NCT07011628Recruiting
Transition to outpatient weight-loss surgery trial
This study tests if sending you home the same day after weight-loss surgery is safe and effective. You must have a BMI of 60 or less and be getting your first sleeve gastrectomy or gastric bypass at Vanderbilt University Medical Center.
Nashville, TennesseeAges 25–55 - NCT07012967Recruiting
Taping for breathing and sleep in obesity
This study tests whether kinesio taping improves breathing and sleep quality in people who are overweight or have class 1 or 2 obesity. You will wear a special tape on your body to see if it helps you breathe better and sleep well.
IstanbulAges 18–70 - NCT06994650RecruitingPhase 3
Study of HRS9531 for sleep apnea and obesity
This trial tests an injection called HRS9531 to see if it helps people with obstructive sleep apnea (OSA) and obesity who already use a CPAP or similar breathing device. It may help by reducing weight and improving breathing during sleep.
Beijing, Beijing MunicipalityAges 18–75 - NCT07001865Enrolling by invitation
Effects of healthy obesity on liver and uric acid risks
This study looks at people who are metabolically healthy but overweight or obese, and how that affects their risk of developing fatty liver disease (MASLD) or high uric acid levels (hyperuricemia). It aims to see if 'healthy' obesity still carries hidden health risks.
NingboAges 18–100 - NCT06996431Enrolling by invitation
Weight loss program with mobile health support
This study tests a new way to help adults lose weight using a smartphone app and health coaching. You might qualify if you are overweight, live in Hong Kong, speak Chinese, and can walk without help.
Hong KongAges 18 years+ - NCT06934681Recruiting
Exercise Program to Help Fight Obesity
This study tests whether a structured exercise program can help people with severe obesity lose weight and improve health. You will be asked to follow a supervised exercise routine to see if it helps you achieve your weight loss goals.
Valencia, ValenciaAges 18–65 - NCT04934228RecruitingPhase 1
Study targeting inflammation in people with obesity and high blood pressure
This Phase 1 study looks at a treatment aimed at reducing “inflammation patterns” that are common in obesity and insulin resistance. If you meet specific health and lab criteria, you may be asked to visit a research lab and provide blood samples to see how the treatment affects your body.
Kansas City, KansasAges 18–79 - NCT06989281Enrolling by invitation
Lifestyle medicine study for UAB patients
This study tests a lifestyle program offered in primary care to help patients manage conditions like diabetes, high blood pressure, high cholesterol, or psoriatic arthritis. It aims to see if this approach can improve health and well-being.
Birmingham, AlabamaAges 18–89 - NCT06991296Recruiting
Omega-3 supplement study for adults with obesity
This study looks at how omega-3 supplements affect certain fats in the blood of adults with obesity. Researchers want to see if taking these supplements changes these fats in a helpful way.
Kannapolis, North CarolinaAges 45–60 - NCT06974851RecruitingPhase 3
Study of HRS9531 for sleep apnea and obesity
This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.
Beijing, Beijing MunicipalityAges 18–75 - NCT06966934Recruiting
Nasal airway and oxygen for stomach scope in obesity
This trial tests whether a breathing tube placed in the nose (nasopharyngeal airway) combined with high-flow oxygen can improve safety during painless gastroscopy in people with obesity. It may help you breathe better while sedated.
NanjingAges 18 years+ - NCT03516968RecruitingPhase 3
Monthly vs daily vitamin D for obese children
This study compares taking vitamin D as a monthly dose versus a daily dose in children with low vitamin D levels. It aims to correct the vitamin D deficiency and see which schedule works best and is safe.
BronAges 5–18 - NCT06946329Enrolling by invitation
Water exercise for knee pain in obese men
This study tests whether a supervised water exercise program (called WATERinMOTION) can reduce knee pain and improve movement in obese men with knee osteoarthritis. It may help if you are looking for a gentle, joint-friendly way to manage your knee pain.
Zahedan, Sistan and BaluchestanAges 45–65 - NCT06948058Recruiting
E-cigarettes vs nicotine therapy for quitting smoking in obesity
This study compares e-cigarettes and nicotine replacement therapy (like patches or gum) to help people who are obese quit smoking. Participants use a study product for 8 weeks and track progress with a smartphone app.
Providence, Rhode IslandAges 21 years+ - NCT06937099RecruitingPhase 3
Testing two drugs for Crohn's with weight issues
This trial tests two study drugs, mirikizumab and tirzepatide, in people with moderate to severe Crohn's disease who also have overweight or obesity. The goal is to see if these treatments can help control Crohn's symptoms and inflammation.
Dothan, AlabamaAges 18–70
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity?
- Yes. Clin2 currently lists 1,434 recruiting obesity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.